CORRECTING and REPLACING Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

NEW YORK–(BUSINESS WIRE)– Please replace the release with the following corrected version due to
multiple revisions.

The corrected release reads:

BRISTOL-MYERS SQUIBB TO HOLD INVESTOR TELECONFERENCE TO DISCUSS ASCO
HIGHLIGHTS

Bristol-Myers
Squibb Company (NYSE:BMY) will host a teleconference on Sunday, June
4, 2017, at 7:30 p.m. EDT (6:30 p.m. CDT) to discuss company strategy
and review data presented at the Annual Meeting of the American Society
of Clinical Oncology (ASCO) in Chicago. Company executives will provide
an overview of company strategy and data presented at the meeting, with
a focus on the company’s immuno-oncology portfolio, and address
inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast
of the call at investor.bms.com,
by dialing toll free (800) 236-0877 or international (719) 457-1036,
confirmation code: 3209540. Materials related to the call will be
available at the same website prior to the call. A replay of the call
will be available beginning at 11:00 p.m. EDT on June 4 through 11:00
p.m. EDT on June 18. The replay can be accessed at investor.bms.com or
by dialing (888) 203-1112 or (719) 457-0820, confirmation code: 3209540.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170526005046/en/